Because management of type 2 diabetes mellitus usually involves combined
pharmacological therapy to obtain adequate glucose control and treatment of concurrent …

Patients with type 2 diabetes mellitus often require multifactorial pharmacological treatment
due to different comorbidities. An increasing number of concomitantly taken medications …

Summary Non-insulin-dependent (type 2) diabetes mellitus (NIDDM) affects middle-aged or
elderly people who frequently have several other concomitant diseases, especially obesity …

There is a growing epidemic of type 2 diabetes (T2DM), and it is associated with various
comorbidities. Patients with T2DM are usually treated with multiple drugs, and are therefore …

The incidence of type 2 diabetes mellitus is increasing rapidly, as are the associated co-
morbidities. Consequently, it has become necessary for a diabetic patient to take multiple …

Type 2 diabetes mellitus is a progressive disorder, and although oral monotherapy is often
initially successful, it is associated with a high secondary failure rate, which contributes to …

Metformin is the world's most commonly used oral glucose-lowering drug for type 2 diabetes,
and this is mainly because it protects against diabetes-related mortality and all-cause …

In this review we present the agents that are in use in the treatment of type 2 diabetes.
Sulfonylureas of the 1 st and 2 nd generation increase insulin secretion but can induce …

Lipid‐lowering drugs, especially 3‐hydroxy‐3‐methylglutaryl–coenzyme A inhibitors
(statins), are widely used in the treatment and prevention of atherosclerotic disease. The …

Background: Type 2 diabetes is progressive in nature and so to control cardiovascular risk,
most patients need combinations of oral antidiabetic drugs (OADs) plus or minus insulin …